The Current Ratio as of December 2025 (TTM) for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is 0.90

According to Taiwan Advance Bio-Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.90. This represents a change of 1.85% compared to the average of 0.88 of the last 4 quarters.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Historical Current Ratio (quarterly & annually)

How has 4186.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Taiwan Advance Bio-Pharmaceutical Inc. over the last ten years is 1.12. The current 0.90 Current Ratio has changed 7.87% with respect to the historical average. Over the past ten years (40 quarters), 4186.TWO's Current Ratio was at its highest in in the December 2020 quarter at 1.61. The Current Ratio was at its lowest in in the June 2019 quarter at 0.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Taiwan Advance Bio-Pharmaceutical Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Average Current Ratio

How has 4186.TWO Current Ratio performed in the past?

The current Current Ratio of Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Current Ratio vs. Peers

How is 4186.TWO’s Current Ratio compared to its peers?

Taiwan Advance Bio-Pharmaceutical Inc.’s Current Ratio is less than LabTurbo Biotech Corporation (14.89), less than Bio Preventive Medicine Corp. (19.06), less than Lukas Biomedical Inc. (1.21), less than NeoCore Technology Co., Ltd. (1.59), less than Level Biotechnology Inc. (1.63), less than MegaPro Biomedical Co., Ltd (4.34), less than TCI GENE Inc. (5.74), less than BiOptic Inc. (6.27), less than Neith Corporation (15.65), less than LAUNXP Biomedical Co., Ltd (7.53),

Build a custom stock screener for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiwan Advance Bio-Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taiwan Advance Bio-Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.